Vital Therapies reported $0 in Debt for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Biomarin Pharmaceutical BMRN:US $ 1080.06M 0.98M
Dynavax Technologies DVAX:US $ 220.76M 0.27M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Epizyme EPZM:US $ 232.49M 0.38M
Insmed INSM:US $ 806.79M 225.49M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
Mirati Therapeutics MRTX:US $ 0M 0M
Omeros OMER:US $ 313.9M 517K
Orasure Technologies OSUR:US $ 2.91M 0.02M
Quidel QDEL:US $ 0M 0M
Regulus Therapeutics RGLS:US $ 4.41M 0.26M
Revance Therapeutics RVNC:US $ 449.74M 169.1M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.98M
United Therapeutics UTHR:US $ 800M 0M
Vital Therapies VTL:US $ 0M 0M
Xoma XOMA:US $ 0 0